Tender detail

Open-house originator discount agreements 2026-14 for crizotinib

Summary

Participating health insurance funds intend to conclude non-exclusive discount agreements with suitable pharmaceutical companies for the active ingredient crizotinib. The open-house agreements run from 1 December 2026 for up to 24 months and end no later than 30 November 2028; they may end earlier if patent protection or market exclusivity expires.

Reference number
4260d3b4-cdc4-4fa3-9d0b-94c0e6b549c3
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-11-30
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.